Повторні операції за раку щитоподібної залози

Ю. М. Стернюк

doi:10.24026/1818-1384.1(22).2008.118334

Автор(и)

Ю. М. Стернюк Львівський національний медичний університет імені Данила Галицького, Львів, Ukraine

DOI:

https://doi.org/10.24026/1818-1384.1(22).2008.118334

Ключові слова:

thyroid cancer, reoperation, completion, indication, technique

Анотація

Reoperation for thyroid cancer need to consider patient, tumor and therapy related aspects as well as present diagnostic results. Reoperations for thyroid remnants, persistence of the primary tumor and lymph node metastasis (completion surgery) has to be distinguished from reoperation due to locoregional recurrence (primary tumor, lymph nodes). The primary surgical strategy should avoid the need for operation. The surgery for cure and limited surgery for cure are singed out. The optimal treatment is obtained by surgery for cure. The extent of reoperation is related to the extent of primary surgery, stage and distant metastasis. The timing and indication of differentiated thyroid carcinoma reoperation in an interdisciplinary multimodal treatment setting depend on diagnostic radioiodine scans and radioiodine therapy. Due to the biological features of the medullar cancer, the main accent of the therapy is pointed on the surgical treatment. Long-term, recurrence-free survival is achieved by sufficiently radical surgery with acceptable morbidity, including all additive or adjuvant treatment options.

Біографія автора

Ю. М. Стернюк, Львівський національний медичний університет імені Данила Галицького, Львів

Ю.М. Стернюк

Посилання

Білинський Б. Т., Нідерле Б., Стернюк Ю. М., Вовк В. С. Локальні рецидиви при хірургічному лікуванні раку щитоподібної залози. Клінічна ендокринологія та ендокринна хірургія. 2003; 3: 28-31.

Ларін О. С., Черенько С. М., Горобейко М. Б. Щодо відповідності тактики лікування раку щитоподібної залози в Україні до європейського консенсусу 2006 року. В кн: Современные аспекты хирургического лечения эндокринной патологии. Первый Украинско-оссийский симпозиум по эндокринной хирургии с международным участием. Киев, Украина, 2006; 8-9.

Стернюк Ю. М., Билынский Б. Т. Итоги и перспективы хирургического лечения рака щитовидной железы. Новоутворення 2007; 1:128-133.

Стернюк Ю. М., Білинський Б. Т., Вовк В. С., Ніедерле Б. Хірургічні роздуми щодо тиреоїдектомії і лімфаденектомії при раку щитоподібної залози. Acta medica Leopoliensia 2005; Vol. 11, 3: 116-128.

American College of Endocrinology AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. Endocr Pract 2001; 7: 202-220.

Deutsche Krebsgesellschaft und Deutschen Gesellschaft fur Chirurgie. Maligne Schilddrusentumoren. Interdisziplinare Leitlinie der Deutschen Krebsgesellschaft und Deutschen Gesellschaft fur Chirurgie. 3. Auf. Dtsch Krebsges. 2002.

Dralle H, Gimm O. Lymph node excision in thyroid carcinoma. Chirurg 1996; 67: 788-806.

Dralle H. Inzidentalome der Schilddruse. Chirurg 2007; 78: 677-686.

Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage—oriented approach justified? Surgery 1997; 122: 1124-1130.

Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 1998; 22: 562-567.

Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Roher HD. Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993; 80: 1009-1012.

Hai ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in 50-year period. Surgery 1992; 112: 1139-1146.

Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind Ch. TNM-Atlas, Springer, Berlin—Heidelberg New York. 1998.

Kebebew E, Kikuchi S, Duh QY, Clarc OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg 2000; 135: 895-901.

Lippert H. Anatomie. Munchen-Jena: Urban Fischer, 2003.

Lippi F, Capezzone M, Miccoli P et al. Use of surgicall gamma probe for the detection of lymph node metastases in differentiated thyroid cancer. Tumori 2000; 86: 367-369.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, Sherman Sl. Prognostic factors in patients with Hurthle cell neoplasms of the thyrooid. Cancer 2003; 97: 1186-1194.

Machens A, Hince R, Lautenschlager C et al. Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: Prediction of extrathyroidal soft tissue infiltrates. Thyroid 2001; 11: 381-384.

Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002; 26: 22-28.

Negele T, Meisetschlager G, Bruckner T, Scheidhauer K, Schwaiger M, Vogelsang H. Radio—guided surgery (RGS) for persistent papillary thyroid cancer: case presentations and possible indications (submitted) 2005.

Niederle B, Zimmermann G, Ladurner D, et al. Schilddrusencarcinom. ACO-Manual. Schidrusenkarzinom. Kapitel 6. http://www.aco.at/manual/schilddr/kap_o6.html.

Pichlmayr R, Groteluschen B (Hrsg) Chirurgische Therapie. Springer, Berlin, 1978; S 1-42.

Proye C. Medullary thyroid carcinomas: persistent hypercalcitoninemia after surgery, reoperations—results. Ann Chir 2003; 128: 289-292.

Roeher HD, Simon D, Witte J, Goretzki PE. Principals of limited or radical surgery for differentiated thyroid cancer. Thyroidololy 1993; 5: 93-96.

Scheumann GF, Seeliger H, Musholt TJ, Gimm O, Wegener C, Dralle H, Hundeshagen H, Pichlmayr R. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996; 162: 677-684.

Sherman Sl (2003) Thyroid carcinoma. Lancet 2003; 361: 501-511.

Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma World J Surg 1996; 20: 860-866.

Timmermann W, Hamelmann WH, Thomusch O et al. Effectiveness and results of intraoperative neuromonitoring in thyroid surgery. Statement of the Interdisciplinary Study Group on intraoperative Neuromonitoring of Thyroid Surgery. Chirurg 2004; 75: 916-922.

Udelsman R, Westa WH, Donovan PI et al. Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 2001; 233: 716-722.

Vini L, Harmer C. Management of thyroid cancer. Lancet Oncol 2002; 3: 407-414.

Vogelsang H, Bruckner T, Scheidhauer R, Schwaiger M, Siewert J. R. Wiederholungseingriffe beim Schilddrusenkarzinom. Chirurg 2005; 76: 238-249.

Walgenbach S, Junginger T Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant? Zentralbl Chir 2002; 127: 435-438.

Watkinson JC. The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun 2002; 25: 897-900.

Widder S, Pasieka JL (2004) Primary thyroid lymphomas. Curr Treat Options Oncol 2004; 5: 307-313.

Wittekind Ch, Meyer HJ, Bootz F. TNM Klassification maligner Tumoren. Springer, Berlin Heidelbeerg New York 2002.